Aminoglycoside-induced proteinuria may result from general renal damage or may reflect alterations in specific steps in the renal handling of proteins. To differentiate between the two possibilities, experiments were designed to quantify the effects of nephrotoxic doses of gentamicin, tobramycin and netilmicin in the intact rat, isolated perfused rat kidney (IPK) and kidney slices using the cationic low molecular weight protein lysozyme as a model protein. Each aminoglycoside was administered IP to male Wistar rats (15 or 30 mg/kg/day) for 5 or 7 days.
Renal Ultrastructural and Biochemical Injuries Induced by Aminoglycosides by Constantin Cojocel,* N. Docius,t Keizo Maita,* Jacqueline H. Smith* and Jerry B. Hook* Aminoglycoside-induced proteinuria may result from general renal damage or may reflect alterations in specific steps in the renal handling of proteins. To differentiate between the two possibilities, experiments were designed to quantify the effects of nephrotoxic doses of gentamicin, tobramycin and netilmicin in the intact rat, isolated perfused rat kidney (IPK) and kidney slices using the cationic low molecular weight protein lysozyme as a model protein. Each aminoglycoside was administered IP to male Wistar rats (15 or 30 mg/kg/day) for 5 or 7 days.
Scanning and transmission electron microscopy indicated that gentamicin and tobramycin induced a decrease in the number and diameter of endothelial fenestrae and degranulation of the myoepithelioid cells of the juxtaglomerular apparatus. Concurrently, gentamicin and tobramycin decreased the glomerular sieving coefficient of lysozyme from 0.8 to 0.6 and 0.5, respectively. Netilmicin did not affect the percentage reabsorption of lysozyme whereas gentamicin and tobramycin induced a 50% decrease in lysozyme reabsorption by the IPK. Gentamicin and tobramycin decreased equally lysozyme degradation by the IPK; this decrease was time-and dose-dependent when evaluated in slices from renal cortex. Perfusion of rat kidneys with gentamicin induced a dose-dependent decrease in reabsorption and catabolism of lysozyme.
In conclusion, these studies demonstrate that polycationic aminoglycosides alter ultrastructure and glomerular permeability, tubular reabsorption and intracellular digestion of proteins.
Aminoglycoside antibiotics are valuable therapeutic agents which are employed frequently in clinical management of gram-negative bacterial infections. Nephrotoxicity, a major side effect of aminoglycoside treatment, is usually characterized by a fall in glomerular filtration rate (GFR), decreased urinary concentrating capacity, proteinuria, enzymuria and ultrastructural alteration of proximal tubular cells. For several years, efforts of various research groups have focused on detection and assessment of the mechanisms of aminoglycoside nephrotoxicity. Luminal uptake is the major route of aminoglycoside tubular reabsorption and subsequent intracellular accumulation (1-3). Contraluminal uptake of aminoglycosides (4,5) also appears to contribrute to the accumulation of aminoglycosides. Although aminoglycosides inhibit Na, K-ATPase activity, it is unlikely that this is the primary mechanism of aminoglycoside nephrotoxicity (6) . The effects of aminoglycosides on mitochondrial, (7) and lysosomal function (8) (9) (10) (11) (8) , though this is still disputed (12) (13) (14) . Low molecular weight proteins (LMWP) are well filtered by the glomerulus and almost totally reabsorbed by the tubule in control conditions. Renal handling of LMWP such as lysozyme and P2-microglobulin appears to be an early target in aminoglycoside nephrotoxicity (15, 16 Following aminoglycoside treatment, sodium iodoacetate was added to the perfusate (3-5 mM) to completely inhibit tubular reabsorption of lysozyme (17) . Aminoglycoside treatment decreased the GSCLY from a control value of 0.8 to 0.6 and 0.5 in kidneys from gentamicin-and tobramycin-treated rats, respectively; netilmicin had no effect. Scanning and transmission electron microscopy indicated that gentamicin and tobramycin altered the ultrastructure of the glomerular endothelium by reducing diameter and frequency of endothelial fenestrae ( Fig. 2 and Table 1 ). Quantitative morphometric studies using data from scanning electron microscopy (Table 1) supported previous studies (18) and demonstrate that aminoglycoside treatment decreased the number of glomerular capillary endothelial fenestratrae. Glomerular functional and ultrastructural alterations caused by aminoglycoside treatment could be induced through a tubuloglomerular feedback mechanism mediated by the renin-angiotensin system which has been suggested to be related to the pathogenesis of acute renal failure by Thurau et al. (19) . Consistent with this hypothesis, high doses of gentamicin (120 mg/kg/day) produced a significant increase in plasma renin activity and a concurrent decrease in GFR in rats (20) . Lower doses of gentamicin or tobramycin (30 mg/kg/day) induced an almost complete depletion of cytoplasmic granules from the myoepitheliod cells in the afferent arterial wall of the juxtamedullar apparatus as revealed by transmission electron microscopy ( Fig. 3) . At the same dose, depletion of cytoplasmic granules was less severe in netilmicin-treated rats. However, in these studies, there was no disintegration of the granules, elevated exocytotoxic excretion processes, or activation of rough endoplasmic reticulum. Thus, it is uncertain whether the depletion of the cytoplasmic granules from the myoepithelioid cells after aminoglycoside treatment was related to activation of the renin-angiotensin system. The precise role played by this system in aminoglycoside-induced renal failure remains to be clarified by further studies. Effects of aminoglycosides on electrolyte excretion in intact rats. Excretion of sodium and potassium in control and aminoglycoside-treated rats for 7 days (30 mg/kg/day). C = control, G = gentamicin, K = kanamycin, N = netilmicin. From Cojocel and Hook (33 (16) . These functional alterations suggest an impairment of tubular reabsorptive capacity. Indeed, increased urinary excretion of sodium and potassium are found in aminoglycoside-treated rats (Fig. 4) . In these experiments gentamicin appeared to have a much more pronounced effect than netilmicin. The specific mechanism by which aminoglycosides decrease tubular reabsorption of electrolytes is still unknown.
Aminoglycoside treatment leads to an increased excretion of brush border enzymes (22) , lysosomal enzymes (23) and LMWP such as P2-microglobulin and lysozyme (16) . Aminoglycoside-induced functional alterations were detected by measuring the urinary excretion of the LMWP lysozyme, the lysosomal enzyme N-acetyl-,3-D-glucosaminidase and total proteins in intact rats (Table 2) . Gentamicin was more potent than netilmicin in decreasing tubular reabsorption of lysozyme and induced damage to cellular membranes causing leakage of the lysosomal marker enzyme NAG and an increase in total protein excretion (Table 2) . Thbular reabsoption of lysozyme had a tendency to return toward control despite continued administration of gentamicin or tobramycin (15) . Determination of the glomerular sieving coefficient of lysozyme after aminoglycoside treatment allowed a more accurate quantitation of tubular reabsorption of lysozyme (Table 3) . Gentamicin and tobramycin (30 mg/kg/day) decreased endocytic reabsorption of lysozyme in isolated perfused kidneys to about 50% after 7 days of treatment. Since aminoglycosides and lysozyme are taken up into tubular 
Decrease of Lysosomal Proteolysis
Protein degradation in the kidney occurs mainly in lysosomes, organelles that are known to accumulate nephrotoxicants such as aminoglycosides. Gentamicin labilizes the lysosomal membrane causing increased release of lysosomal marker enzymes to the incubation medium in vitro (24) and increased excretion of lysosomal enzymes in vivo (25) . Likewise, gentamicin treatment of rats led to a decrease of lysosomal protein degradation by renal cortical slices in a dose-related fashion (26) (Fig. 5) . In these studies, the effects of gentamicin on lysosomal degradation of lysozyme by renal cortical slices was measured as free (nonprecipitable) radioactivity and was expressed as percentage of total radioactivity released to the incubation medium. The effects of gentamicin, tobramycin and netilmicin on renal protein degradation were compared (Fig. 6 ) in the isolated perfused rat kidney (8 4.5 ,umole. Netilmicin appeared to have no effect on renal degradation of lysozyme (Fig. 6 ). This study also showed that gentamicin and tobramycin had similar effects on renal protein catabolism. The decrease in renal catabolism of lysozyme may be due indirectly to decreases in glomerular filtration rate, the glomerular sieving coefficient of lysozyme, and impairment of tubular endocytic uptake of lysozyme. The direct effect of aminoglycosides on lysosomal protein degradation may be due to an increase in intralysosomal pH and subsequent decrease in the activity of proteolytic enzymes. Treatment of rats with gentamicin decreased the lysosomal activity of cathepsin B (11) , a proteolytic enzyme responsible for the lysosomal breakdown of egg white lysozyme (27) .
Acute Effects of Gentamicin
Cationic LMWP such as lysozyme and cytochrome c compete for anionic binding sites at the proximal tubule brush border, the first step in endocytic tubular reabsorption (1, 28, 29) . Similar competition between polyeationic aminoglycosides appears to take place in (Fig. 8) . This inhibition could be due primarily to inhibition of tubular reabsorption of lysozyme by gentamicin (Fig. 7) and additionally to the inhibition of enzymatic activity of lysosomal proteases responsible for the lysosomal catabolism of lysozyme. In summary, aminoglycosides act as nephrotoxicants at the glomerulus, by reducing the glomerular filtration of inulin and cationic proteins, at the tubule by inhibiting the endocytic reabsorption, and at the lysosome, by decreasing the proteolytic activity of lysosomal enzymes.
